Ceftolozane/Tazobactam for the Treatment of Complicated Infections in Hospital Settings-A French Real-world Study.

Jean François TimsitJoy MootienBrune AkrichXavier BourgeIsabelle BrassacBernard CastanCarole MackossoLinsay Monteiro TavaresFabrice RuizDavid BoutoilleRaymond Ruimy

Published in: Open forum infectious diseases (2024)

This is the first prospective observational study of C/T utilization in a health care setting enrolling many patients in France. C/T demonstrated a high rate of clinical effectiveness in MDR infections, confirming it as an effective treatment option for complicated infections in a high-risk population.

Keyphrases

healthcare
end stage renal disease
randomized controlled trial
ejection fraction
chronic kidney disease
multidrug resistant
emergency department
peritoneal dialysis
prognostic factors
gram negative
combination therapy
patient reported outcomes